Synthesis and pharmacological characterization of 5-phenyl-2-[2-(1-piperidinylcarbonyl)phenyl]-2,3-dihydro-1 H-pyrrolo[1,2- c]imidazol-1-ones: A new class of Neuropeptide S antagonists
A new lead series was identified in the NPS antagonist field. The compound was prepared following up experimental observations rationalized with computational chemistry techniques and rational design. A new class of selective NPS antagonist was developed starting from a commercially available produc...
Saved in:
Published in | Bioorganic & medicinal chemistry letters Vol. 20; no. 24; pp. 7308 - 7311 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Ltd
2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A new lead series was identified in the NPS antagonist field. The compound was prepared following up experimental observations rationalized with computational chemistry techniques and rational design.
A new class of selective NPS antagonist was developed starting from a commercially available product identified by screening activities. Experimental NMR observations and computational experiments allowed the discovery of a new class of derivatives. 5-Phenyl-2-[2-(1-piperidinylcarbonyl)phenyl]-2,3-dihydro-1
H-pyrrolo[1,2-
c]imidazol-1-one represents a new lead compound in the NPS antagonist field. |
---|---|
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2010.10.067 |